Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05479461 · ClinicalTrials.gov registry record · NA
Technology-enabled Management Versus Usual Care for Blood Pressure
A NA study of Hypertension, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 3
- Study locations
NCT05479461: Recruiting NA study of Hypertension, sponsored by Stanford University.
NCT05479461 is a NA study of Hypertension that is actively recruiting participants, run by Stanford University. The registered enrollment target is 200 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05479461, a NA study of Hypertension, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 3
- Study locations
Study Summary
Two arm parallel randomized clinical trial
Primary Outcome
Change in defined daily dose (DDD)
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Digital Hypertension Management System
Study Locations (3)
Georgia
- Morehouse School of Medicine - Atlanta
- Lake Country Medical Group - Eatonton
California
- Stanford Health Care - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-13 |
| Est. Completion | 2025-09-15 |
| Phase | NA |
What NCT05479461 shows while recruiting
NCT05479461 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05479461 reports a single indexed study location in Georgia, California.
Frequently Asked Questions
What is clinical trial NCT05479461 about?
NCT05479461 is a clinical study titled "Technology-enabled Management Versus Usual Care for Blood Pressure". Two arm parallel randomized clinical trial
What is the current status of trial NCT05479461?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-06-13. Estimated completion is 2025-09-15.
What conditions does trial NCT05479461 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT05479461?
The interventions under investigation include: Usual Care (OTHER), Digital Hypertension Management System (OTHER).
Who is sponsoring clinical trial NCT05479461?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05479461 being conducted?
This trial has 3 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05479461's enrollment target sits among peer trials
200 219th of 470 higher than 246 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI